Fundz

CytoSorbents Appoints Alexander D'Amico as Chief Financial Officer

PUBLIC · CTSOJul 19, 2023

Company

CytoSorbents Corporation

Alexander D'Amico
Monmouth JunctionManufacturingBiotechnologyHealth Care

Description

PRINCETON, N.J. , July 19, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the appointment of Alexander D’Amico as Chief Financial Officer, to begin employment on August 7, 2023 .

Quick answer

CytoSorbents Appoints Alexander D'Amico as Chief Financial Officer (July 19, 2023). CytoSorbents Corporation is based in Monmouth Junction, New Jersey, United States.

What did CytoSorbents Corporation announce on July 19, 2023?
PRINCETON, N.J. , July 19, 2023 -- CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the appointment of Alexander D’Amico as Chief Financial Officer, to begin employment on August 7, 2023 .
What does CytoSorbents Corporation do?
CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology.
Where is CytoSorbents Corporation based?
CytoSorbents Corporation is based in Monmouth Junction, New Jersey, United States.
Which similar companies made leadership changes around the same time?
AbbVie Inc. (June 29, 2023), BioPhotas (August 8, 2023), Tegra Medical (June 27, 2023) and KORU Medical Systems (June 27, 2023) also announced leadership changes within 45 days of CytoSorbents Corporation.

Source: Fundz verified event record.

Other recent leadership changes in Manufacturing and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at CytoSorbents Corporation, and when

A new leader at CytoSorbents Corporation brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day CytoSorbents Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CytoSorbents Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CytoSorbents Corporation. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CytoSorbents Corporation

Location

Monmouth Junction, New Jersey, United States

About

CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology. CytoSorbents is a leader in the treatment of life-threatening conditions in the ICU and cardiac surgery using blood purification. Its flagship product, CytoSorb®, is distributed in more than 70 countries and has CE Mark approval in the EU for cytokine, bilirubin and myoglobin removal in numerous critical care applications and the removal of ticagrelor and rivaroxaban during cardiothoracic surgery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CytoSorbents Corporation changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Phillip
Likely contact at this company
••••••••@••••••••

See Phillip's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for CytoSorbents Corporation's next move

Learn about Strategic plan

CytoSorbents Corporation changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.